"Tested" is not one thing.
Endotoxin assays, PCR screens, and true sterility testing are three different measurements with three different failure modes — and the market sells all three under one word. Here is the microbiology underneath the certificates, and what a pass on each test actually commits a vendor to.
The short version: endotoxin testing [USP <85>, the LAL assay] measures a heat-stable bacterial residue that survives filtration. PCR screening looks for microbial DNA above a detection floor. Sterility testing [USP <71>] is a roughly 14-day culture that looks for living organisms and destroys the vials it tests — and almost nobody in this market runs it. The three are not interchangeable, a pass on one says nothing about the others, and for injectable-format compounds the minimum a buyer should demand is lot-specific endotoxin data reported as a number against a stated threshold.
- Endotoxins are lipopolysaccharide fragments of dead gram-negative bacteria — heat-stable, fever-inducing, and able to pass straight through the sterile filter that removed the bacteria themselves.
- The LAL assay [USP <85>] measures that residue against a threshold. Duplicates and controls are what make the number trustworthy — a single uncontrolled reading is close to decoration.
- A PCR screen detects microbial DNA. It can flag dead organisms and miss live ones below its detection floor — it is a contamination screen, not a sterility result.
- USP <71> sterility testing takes about 14 days and destroys the units it tests. That is why the research market almost never runs it — and why casual "sterility assured" language should be read as marketing.
- "Sterile" on bacteriostatic water is a form descriptor about a manufacturing process. It is not a test result on your peptide lot, and vendors trade on the confusion.
Read the COA guide first — this is the layer under it
Our guide to reading a certificate of analysis covers the five measures a trustworthy document reports and how to verify one. This piece assumes that and goes one level down, into the microbiology the certificate is summarizing — because the market's favorite trick is not fake documents. It is real documents describing modest tests, sold under words that imply bigger ones. To see through that, you need to know what each test physically does.
Endotoxin: the contaminant that survives sterilization
Start with the molecule, because everything else follows from its properties. Endotoxins are lipopolysaccharide fragments — pieces of the outer cell wall of gram-negative bacteria, shed while the organisms are alive and released in bulk when they die. Three properties make them the central quality question for anything in injectable format:
- They are pyrogenic at tiny doses. The mammalian immune system treats lipopolysaccharide as a primary invasion signal; parenteral exposure drives fever and inflammatory response at doses measured in fractions of a microgram.
- They are heat-stable. Conditions that kill every living organism in a vial leave endotoxin largely intact. You cannot autoclave your way out of an endotoxin problem.
- They pass sterile filters. A 0.22-micron filter removes bacteria. The wall fragments of bacteria that died upstream — in the water, in the synthesis, on the equipment — sail through.
Hold those three facts together and the market's core confusion dissolves: a lot can contain zero living organisms and still be pyrogenic. Killing the bacteria is not the same as removing what their walls left behind. This is why endotoxin gets its own pharmacopeial chapter, its own assay, and its own line on serious certificates — and why no sterility claim, true or false, answers the endotoxin question.
The LAL assay — and why the details on the certificate matter
The standard method is the bacterial endotoxins test of USP <85>, built on LAL — limulus amebocyte lysate, a reagent derived from horseshoe crab blood cells, which clots in the presence of endotoxin with remarkable sensitivity. The assay comes in gel-clot and photometric variants, and results are reported in endotoxin units against a threshold set by the product's dose and route.
When you see LAL data on a certificate, the reporting format tells you how seriously the lab took it. Three things separate a real result from a checkbox:
- A number, not a word. "<0.5 EU/mg" is a measurement. "Endotoxin: pass" is a claim about a measurement you are not being shown.
- A stated threshold. A number only means something against the limit the lab applied — a serious document states both.
- Duplicates and controls. Good labs run samples in duplicate with positive product controls, because peptide matrices can inhibit or enhance the reaction and quietly corrupt a single reading. Duplicate agreement is what converts a reading into a result.
One development worth knowing about: recombinant factor C [rFC] reagents — synthetic alternatives to crab-derived lysate — have moved from the sustainability literature into the pharmacopeias, and USP has recognized recombinant-reagent methods in a dedicated chapter. For a buyer the distinction is minor; an endotoxin number from a competent lab is the point, whichever reagent produced it.
PCR screening: what a DNA test can and cannot see
The second test that shows up on better certificates is a PCR microbial screen — amplification chemistry looking for microbial DNA in the sample. It is a real test with real value, and it is routinely oversold, so be precise about both directions of its blindness.
What it can miss: PCR has a detection floor. Viable organisms present below that floor — or organisms whose signatures the panel does not target — produce a clean result. "No detectable microbial DNA" is a statement about the assay's sensitivity, not a guarantee of absence.
What it can falsely flag: DNA does not die when its organism does. A sample can carry amplifiable DNA from organisms killed long ago in processing — harmless residue reading as a hit. PCR cannot distinguish a live contaminant from a ghost.
Put both limits together and the correct reading is: a PCR screen is a useful contamination check that is neither necessary nor sufficient for sterility. On a certificate it earns respect as an extra layer, never as a substitute for the two tests on either side of it.
USP <71>: what sterility testing actually costs
True sterility testing is USP <71>, and its mechanics explain the market's behavior better than any accusation could. The method incubates product in two growth media — one favoring bacteria, one favoring fungi — for roughly 14 days, watching for any growth. Three consequences follow:
- It is slow. Two weeks of incubation before a lot can claim the result — an eternity for vendors whose inventory turns weekly.
- It is destructive. The vials tested are consumed. Sampling enough units to make the result meaningful means destroying sellable product from every lot.
- It punishes sloppiness in both directions. The test must itself be run under contamination-controlled conditions, because a technician's stray organism condemns a clean lot. Labs that run <71> properly are running cleanroom operations to test for cleanroom failures.
Pharmaceutical manufacturers absorb all three costs because regulation requires it. Research-market vendors face no such requirement, and almost none volunteer — which is rational economics and worth saying plainly rather than darkly: the problem is not that vendors skip <71>, it is that their marketing implies they did not. When a product page says "sterility assured" and the certificate shows an LAL number and a PCR screen, the words and the documents disagree, and the documents are the ones telling the truth.
"Sterile" the adjective versus sterility the result
One more distinction the market blurs, this one subtler. Bacteriostatic water and other diluents sold alongside peptides are commonly labeled sterile — legitimately. On those products, "sterile" is a form descriptor: it says the product is manufactured and filled under an established sterile process, a claim about how a production line operates. A sterility test result on a peptide lot is a different object entirely — a measurement performed on that specific lot after filling.
Both usages are legitimate in their own lanes. The trouble is adjacency: a vendor page showing sterile-labeled diluent next to peptide vials lets the adjective drift sideways onto products it was never tested on. When you read "sterile" anywhere in this market, the question to ask is mechanical: is this word describing a process claim on a diluent, or a <71> result on the lot in my hand. They are almost never the second.
How aseptic fill works — and where it fails
Since almost no research lot is sterility-tested, what stands between a buyer and contamination is process: sterile filtration plus aseptic fill. In practice that means the reconstituted bulk solution is passed through a 0.22-micron filter — which removes organisms, not endotoxin — directly into vials, inside an environment intended to keep new organisms out, followed by capping and typically lyophilization.
The chain fails at its human links. The filter itself is reliable; what fails is everything around it — vials or stoppers inadequately depyrogenated, filling environments that are a bench and a wiped-down hood rather than a qualified cleanroom, operators shedding organisms over open vials, and endotoxin already accumulated upstream in the water or the raw powder before filtration ever happened. This is why the two cheap tests are so informative despite their limits: an endotoxin number audits the upstream water-and-handling chain, and a PCR screen samples the downstream fill environment. Where your raw powder was synthesized — and how many hands it passed through before filling — is its own story, covered in our supply-chain report.
What a buyer should actually demand
For injectable-format research compounds, the reasonable floor is not sterility testing — demanding <71> from this market is demanding a document nobody will produce. The reasonable floor is: lot-specific endotoxin data, reported as a number against a stated threshold, on a certificate naming the lab, verifiable per the steps in our COA guide. A PCR microbial screen on the same document is a meaningful upgrade. Anything beyond that is a bonus so rare it functions as a vendor-identification feature. And any adverse reaction to a compound with no such data behind it belongs in the side-effects framework as an unknown-quality event, not just an unknown-compound event — the vial, not the molecule, may be the variable.
The field guide: what each phrase commits to
| test | method | what a pass means | what it cannot tell you |
|---|---|---|---|
| Endotoxin | LAL · USP <85> [or rFC] | Pyrogenic bacterial residue sits below the stated threshold in the tested sample. | Whether viable organisms are present. Not a sterility result. |
| Microbial screen | PCR amplification | No microbial DNA detected above the assay's floor, for the targets on the panel. | Live organisms below the floor; dead-DNA hits; anything off-panel. |
| Sterility | USP <71> · 14-day dual-media culture | No viable growth from the sampled units across the incubation. | Endotoxin load; anything about the unsampled vials in the lot. |
| "Sterile" diluent label | form descriptor | The diluent is produced under an established sterile-fill process. | Anything at all about the peptide lot sold next to it. |
| "Lab tested" [marketing] | unspecified | Some test, on some sample, at some point. Nothing more until the certificate says which. | Everything. The phrase commits to nothing. |
The last two rows are the market-language audit in miniature. "USP grade" deserves the same squint: USP grade describes a material meeting a monograph's standards — it is a purity-and-identity claim about an ingredient, not a microbiological result on a finished lot. Every one of these phrases has a legitimate home; the audit question is always whether the phrase and the document underneath it are the same size.
FAQ
What is an endotoxin, in one sentence?
A heat-stable lipopolysaccharide fragment from the wall of a gram-negative bacterium — fever-inducing at tiny parenteral doses, and able to pass through the sterile filter that removed the bacterium itself.
Is an endotoxin test the same as a sterility test?
No. USP <85> measures a bacterial residue; USP <71> cultures for living organisms over roughly 14 days. A lot can pass either and fail the other, which is exactly why serious documents report them separately.
Why does almost nobody in this market run USP <71>?
It takes about two weeks, destroys the vials it samples, and requires contamination-controlled test conditions where a technician's error condemns a clean lot. Unregulated economics reward the fast cheap tests instead — so sterility language usually turns out to be endotoxin or PCR wearing a bigger word.
Does "sterile" on bacteriostatic water cover the peptide sold next to it?
No. On a diluent, sterile is a form descriptor about that product's manufacturing process. It transfers nothing to a peptide lot, which would need its own <71> result to make the equivalent claim.
What is the minimum testing worth insisting on?
Lot-specific endotoxin data — a number against a stated threshold, from a named lab, on a verifiable certificate. A PCR microbial screen is a strong addition. Treat sterility claims as unproven unless USP <71> appears on the document itself.
References & further reading
- USP General Chapter <85> Bacterial Endotoxins Test — usp.org
- USP General Chapter <71> Sterility Tests — usp.org
- USP, recognition of recombinant-reagent bacterial endotoxins methods [rFC] — usp.org
- FDA, Guidance for Industry — Pyrogen and Endotoxins Testing: Questions and Answers — fda.gov
- FDA, Guidance for Industry — Sterile Drug Products Produced by Aseptic Processing, Current Good Manufacturing Practice — fda.gov
disclosure: this is an evidence piece — it contains no vendor links. inside your peptides may earn referral fees from vendor links elsewhere on the site; grades and rankings follow the published criteria in our editorial policy — never referral terms. research + education only · not medical advice.